EP1765381
TREATMENT OF NEUROLOGICAL DISORDERS WITH HAEMATOPOIETIC GROWTH FACTORS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
29.12.2004EP published:
13.10.2010EP application number:
04806493.5
EPO information:
European Patent Register
Max expiry date:
28.12.2024
Title:
TREATMENT OF NEUROLOGICAL DISORDERS WITH HAEMATOPOIETIC GROWTH FACTORS
Timeline
Today
29.12.2004EP application
13.10.2010EP Publication
Owner
Name:
Sygnis Bioscience GmbH & Co. KGAddress:
Im Neuenheimer Feld 515, 69120, Heidelberg, DE
Inventor
Name:
SCHAEBITZ, Wolf-RuedigerAddress:
Bielefeld, DE
Name:
SCHNEIDER, ArminAddress:
Heidelberg, DE
Name:
KRUEGER, CarolaAddress:
Neustadt/Weinstr., DE
Name:
SOMMER, ClemensAddress:
Nieder-Olm, DE
Name:
SCHWAB, StefanAddress:
Erlangen, DE
Name:
KOLLMAR, RainerAddress:
Erlangen, DE
Name:
MAURER, MartinAddress:
Tübingen, DE
Name:
WEBER, DanielaAddress:
Heidelberg, DE
Name:
GASSLER, NikolausAddress:
Aachen, DE
Priority
Number:
880101Date:
30.6.2004Country:
US
Classification
Categories:
A61K 38/19, A61K 38/20, A61K 35/30, C12N 5/074, A61P 25/28, A61P 25/24, A61P 25/16, A61P 25/14, A61P 9/10, A61P 27/06, A61P 25/02